NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT01177007 2017-08-28Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid TumorsYale UniversityPhase 2 Completed50 enrolled 10 charts